Scientists at OMRF have made new findings that could pave the way for the first drug to treat aortic stenosis.
Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.
An OMRF discovery could potentially open the door for the first drug option to treat age-related muscle weakness and atrophy.
In 1968, doctors told Greg Kindell that he had acute myeloid leukemia and he had just six weeks to live. Now he’s been cancer-free for 50 years.
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
The project will focus on comparing certain immune cells in patients with Sjögren’s to those of healthy controls.